Literature DB >> 11969423

Identification of potential physiological activators of protein phosphatase 5.

Andrew J Ramsey1, Michael Chinkers.   

Abstract

The protein serine/threonine phosphatase designated PP5 has little basal activity, and physiological activators of the enzyme have never been identified. Purified PP5 can, however, be activated by partial proteolysis or by the binding of supraphysiological concentrations of polyunsaturated long-chain fatty acids to its tetratricopeptide repeat (TPR) domain. To test whether activation of PP5 by polyunsaturated but not saturated fatty acids was an artifact of the lower solubility of saturated fatty acids, the effects of fatty acyl-CoA esters were examined. Saturated and unsaturated long-chain fatty acids are both freely water-soluble when esterified to CoA. Long-chain fatty acyl-CoA esters activated PP5 at physiological concentrations, with the saturated compounds being more effective. We investigated the effects of chain length and of the CoA moiety on PP5 activation. Chains of 16 carbons or more were required for optimal activation, with no activation observed below 10 carbons. On the basis of competition studies using acetyl-CoA, the function of the CoA moiety appeared to be to increase solubility of the fatty acyl moiety rather than to interact with a specific binding site. These data suggested that long-chain fatty acid-CoA esters might be physiological activators of PP5 and point to a potential link between fatty acid metabolism and signal transduction via this enzyme. Because heat shock protein 90 is also known to bind to the TPR domain of PP5 via its C-terminal domain (C90), we investigated its effect on PP5 activity. C90 activated the enzyme approximately 10-fold. Thus, we have identified two potential physiological activators of PP5.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11969423     DOI: 10.1021/bi016090h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Molecular chaperones function as steroid receptor nuclear mobility factors.

Authors:  Cem Elbi; Dawn A Walker; Guillermo Romero; William P Sullivan; David O Toft; Gordon L Hager; Donald B DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

2.  Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation.

Authors:  Ambereen Ali; Ji Zhang; Shideng Bao; Irene Liu; Diane Otterness; Nicholas M Dean; Robert T Abraham; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2004-02-01       Impact factor: 11.361

Review 3.  Versatile TPR domains accommodate different modes of target protein recognition and function.

Authors:  Rudi Kenneth Allan; Thomas Ratajczak
Journal:  Cell Stress Chaperones       Date:  2010-12-09       Impact factor: 3.667

Review 4.  Protein phosphatases in pancreatic islets.

Authors:  Henrik Ortsäter; Nina Grankvist; Richard E Honkanen; Åke Sjöholm
Journal:  J Endocrinol       Date:  2014-03-28       Impact factor: 4.286

Review 5.  Tetratricopeptide repeat cochaperones in steroid receptor complexes.

Authors:  David F Smith
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

Review 6.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

7.  The subcellular localization of plant protein phosphatase 5 isoforms is determined by alternative splicing.

Authors:  Sergio de la Fuente van Bentem; Jack H Vossen; Josephus E M Vermeer; Marianne J de Vroomen; Theodorus W J Gadella; Michel A Haring; Ben J C Cornelissen
Journal:  Plant Physiol       Date:  2003-09-04       Impact factor: 8.340

8.  Molecular basis for TPR domain-mediated regulation of protein phosphatase 5.

Authors:  Jing Yang; S Mark Roe; Matthew J Cliff; Mark A Williams; John E Ladbury; Patricia T W Cohen; David Barford
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

9.  Human protein phosphatase 5 dissociates from heat-shock proteins and is proteolytically activated in response to arachidonic acid and the microtubule-depolymerizing drug nocodazole.

Authors:  Tamás Zeke; Nick Morrice; Cristina Vázquez-Martin; Patricia T W Cohen
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ.

Authors:  Lance A Stechschulte; Terry D Hinds; Saja S Khuder; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Mol Endocrinol       Date:  2014-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.